Brain-derived extracellular vesicle microRNAs in Lewy body and Alzheimer's disease
Stephanie J. YangiD, Andrew A. LiniD, Hanfei SheniD, Laura W. Pappalardo, Griffin B. SpychalskiiD, Jean G. RosarioiD, Leah K. ForsbergiD, Kiera M. Grant, Joshua R. BuseriD, Rodolfo SavicaiD, Sid O’Bryant, David T. Jones, Dennis W. DicksoniD, Robert Ross ReichardiD, Aivi T. NguyeniD, David F. MeaneyiD, Bradley F. BoeveiD, Owen A. RossiD, Pamela J. McLeaniD, David IssadoreiD
Abstract
INTRODUCTIONRobust plasma-based biomarkers to distinguish Lewy body disease (LBD) and Alzheimers disease (AD) are currently lacking. We applied track-etch magnetic nanopore (TENPO) sorting for enrichment of brain-derived extracellular vesicle (EV) signatures as potential biomarkers to address this gap. METHODSWe analyzed plasma from 137 autopsy-confirmed patients [30 LBD, 31 AD, 30 AD/LBD, 19 AD with amygdala Lewy bodies (AD/ALB), and 27 controls], sequencing miRNAs from TENPO-isolated GluR2-positive (neuron-enriched) and GLAST-positive (astrocyte-enriched) EVs, and measuring plasma proteins (A{beta}40, A{beta}42, tau, p-Tau181, p-Tau231) via SIMOA. RESULTSWe identified 16 GluR2+, 8 GLAST+, and 4 protein biomarkers with differential expression (false discovery rate-corrected P value < .1) between LBD and AD. A multimodal 15-feature panel classified LBD versus AD with 10-fold cross-validated accuracy = 0.95 and area under the curve (AUC) = 0.96. DISCUSSIONBrain-derived EVs offer accurate and accessible miRNA biomarkers for the differential diagnosis of LBD and AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 12.31
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Platelet miRNA bio-signature discriminates between dementia with Lewy bodies and Alzheimer disease
Ana Gámez‐Valero, Jaume Campdelacreu, … Katrin Beyer·bioRxiv·May 4, 2020
- Proteomic identification and validation of novel neuronal EV-based markers for Alzheimers disease biomarker discovery
Waqar Ahmed, Carlos J. Nogueras‐Ortiz, … Vasiliki Mahairaki·bioRxiv·Apr 29, 2026
- Proteomic and Biological Profiling of Extracellular Vesicles from Alzheimer’s Disease Human Brain Tissues
S. Muraoka, A. M. DeLeo, … T. Ikezu·bioRxiv·Aug 15, 2019
- MiRNA-501-3p and MiRNA-502-3p: A Promising Biomarker Panel for Alzheimer's Disease
Davin Devara, Bhupender Sharma, … Subodh Kumar·Clinical and Translational MedicinePeer-reviewed·Jul 1, 2025
- Different RNA profiles in plasma derived small and large extracellular vesicles of Neurodegenerative diseases patients.
Daisy Sproviero, Stella Gagliardi, … Cristina Cereda·International Journal of Molecular SciencesPeer-reviewed·Mar 8, 2021
- Plasmatic immune extracellular vesicle profiles identify prodromal and early stages of Parkinson's disease
Elena Vacchi, Jacopo Burrello, … Giorgia Melli·bioRxiv·May 14, 2026